MedTrace Logo

GRAFted Patients' anxieTY Report

NCT03675997 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2020-01-29

No results posted yet for this study

Summary

Autograft is a technique requiring several weeks of hospitalization in a protected environment and can be a source of anxiety of different natures for patients. In this study, level of anxiety will be reported weekly throughout hospitalizations for autologous transplant, to detect the most stressful period.

Conditions

  • Autologous Transplant Indication

Interventions

OTHER

HAD (Hospital Anxiety and Depression) scale

HAD (Hospital Anxiety and Depression) scale will be completed and reported by patients the first day of conditioning and then weekly from day 0 corresponding to the autograft, until their last day in the hematological department.

Sponsors & Collaborators

  • Institut de Cancérologie de la Loire

    lead OTHER

Principal Investigators

  • Stéphanie Morisson, MD · Institut de Cancérologie Lucien Neuwirth

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-07
Primary Completion
2019-09-10
Completion
2019-10-20

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03675997 on ClinicalTrials.gov